𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue

✍ Scribed by R. Broll; M. Duchrow; E. Oevermann; C. Wellm; O. Schwandner; H. Schimmelpenning; U.J. Roblick; H.P. Bruch; U. Windhövel

Publisher
Springer
Year
2001
Tongue
English
Weight
62 KB
Volume
16
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Staining patterns of p53 immunohistochem
Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer
✍ Kaserer, Klaus; Schmaus, Judith; Bethge, Ulrike; Migschitz, Brigitte; Fasching, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

Immunohistochemistry (IHC) is a cheap and rapid method to detect p53 inactivation but the results are often discordant with gene mutation analysis. This study aimed to investigate whether there is a difference in the immunohistochemical staining patterns of p53-positive cells on comparing tumours wi

Expression of p53 in oral squamous cell
Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients
✍ Saman Warnakulasuriya; Thierry Soussi; Rehana Maher; Newell Johnson; Mahvash Tav 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Around 50% of head and neck cancers are known to have aberrations of the p53 gene. Overexpression of the mutant p53 protein can induce a specific humoral response in cancer patients. Matched saliva, serum, and tissue samples from 26 patients with histologically confirmed oral squamous and verrucous

p53 antibodies in the sera of lung cance
p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumour tissue
✍ Christopher Paul Wild; Maaret Ridanpaa; Sisko Anttila; Richard Lubin; Thierry So 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 848 KB

## Abstract This study examined the sensitivity and specificity of serum auto‐antibodies to p53 protein as a non‐invasive marker of p53 genetic alterations or protein accumulation in lung cancer cases. A sensitive ELISA to detect serum p53 antibodies was developed and used to examine sera from 186